Slate Bio
Charlottesville, VA
Slate Bio is an immunotherapeutics development company that develops therapies that restore the body's natural immunological response in different diseases using bifunctional IL233 cytokine, thereby providing users with an independent synergistic pathway that has greater tissue selectivity and improved pharmacodynamics.
slatebio.comCompany Details
Founded
- 2020
Employees
- Between 2 - 10 employees
Raised
- $4,526,949
Headquarters Location
- Charlottesville, VA
Public
- No
Acquired
- No
CEO
- Andrew Krouse
Company Collections
These are collections Slate Bio is a part of. Click on the collection name to view similar companies.